Polyurethane Intravaginal Ring for Controlled Delivery of Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor of HIV-1

Journal of Pharmaceutical Sciences - Tập 97 - Trang 4228-4239 - 2008
Kavita M. Gupta1, Serena M. Pearce1, Azadeh E. Poursaid1, Hyder A. Aliyar1, Patrick A. Tresco1, Mark A. Mitchnik2, Patrick F. Kiser1,3
1Department of Bioengineering, University of Utah, Salt Lake City, Utah
2Particle Sciences Inc., Bethlehem, Pennsylvania
3Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah

Tài liệu tham khảo

2006 Glynn, 2001, Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia, AIDS, 15, S51, 10.1097/00002030-200108004-00006 Stone, 2002, Microbicides: A new approach to preventing HIV and other sexually transmitted infections, Nat Rev Drug Discov, 1, 1977, 10.1038/nrd959 Watts, 2001, The impact of microbicides on HIV and STD transmission: Model projections, AIDS, 15, S43, 10.1097/00002030-200102001-00064 Peterson, 2006, OD13 Woolfson, 2006, Potential use of vaginal rings for prevention of heterosexual transmission of HIV: A controlled-release strategy for HIV microbicides, Am J Drug Delivery, 4, 7, 10.2165/00137696-200604010-00002 Faundes, 2004, Pros and cons of vaginal rings for contraceptive hormone delivery, Am J Drug Delivery, 2, 241, 10.2165/00137696-200402040-00004 Roumen, 2002, Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing, Eur J Contracept Reprod Health Care, 7, 19, 10.1080/13625187.2002.11949331 Sarkar, 2005, The combined contraceptive vaginal device (NuvaRing): A comprehensive review, Eur J Contraception Reprod Health Care, 10, 73, 10.1080/13625180500131683 Malcolm, 2003, In vitro release of nonoxynol-9 from silicone matrix intravaginal rings, J Control Release, 91, 355, 10.1016/S0168-3659(03)00260-8 Malcolm, 2005, Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings, J Antimicrob Chemother, 56, 954, 10.1093/jac/dki326 Han, 2007, Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents, Contraception, 76, 132, 10.1016/j.contraception.2007.04.006 Woolfson, 2006, Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide, Int J Pharm, 325, 82, 10.1016/j.ijpharm.2006.06.026 D'Cruz, 2006, Dawn of non-nucleoside inhibitor-based anti-HIV microbicides, J Antimicrob Chemother, 57, 411, 10.1093/jac/dki464 Dezarnaulds, 2003, Vaginal ring delivery of hormone replacement therapy—A review, Expert Opin Pharmacother, 4, 201, 10.1517/14656566.4.2.201 Ballagh, 2001, Vaginal ring hormone delivery systems in contraception and menopause, Clin Obstet Gynecol, 44, 106, 10.1097/00003081-200103000-00014 Oddsson, 2005, Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: A randomized trial, Hum Reprod, 20, 557, 10.1093/humrep/deh604 Woolfson, 2006, Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide, Int J Pharm, 325, 82, 10.1016/j.ijpharm.2006.06.026 Frenkel, 2005, Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability, J Med Chem, 48, 1974, 10.1021/jm049439i Das, 2004, J Med Chem, 47, 2550, 10.1021/jm030558s Motakis, 2002, A tight-binding mode of inhibition is essential for anti-human immunodeficiency virus type 1 virucidal activity of nonnucleoside reverse transcriptase inhibitors, Antimicrob Agents Chemother, 46, 1851, 10.1128/AAC.46.6.1851-1856.2002 Romano J,Coplan P,Mitchnick M,Douville K,Malcolm K,Van Roey J,Temmerman M,Van Bortel L,Weyers S,Rosenberg Z.2006.AIDS 2006 - XVI International AIDS Conference, Toronto, pp Abstract no. WEA A0503. Romano J,Variano B,Coplan P,Roey JV,douville K,Rosenberg Z,Temmerman M,Van Bortel L,Weyers S,Mitchnick M.2007.Sustained Delivery of the Microbicide Dapivirine Using Intra-vaginal Rings: Independent Clinical Assessments of Drug Delivery and Safety in Women. 14th Conference on Retrovirus and Opportunistic Infections ed., Los Angeles, USA. Higuchi, 1963, Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J Pharm Sci, 52, 1145, 10.1002/jps.2600521210 Weisberg, 2000, A randomized comparison of the effects on vaginal and cervical epithelium of a placebo vaginal ring with non-use of a ring, Contraception, 62, 83, 10.1016/S0010-7824(00)00137-2 Demetrio, 1994, Coping with extra Poisson variability in the analysis of factors influencing vaginal ring expulsions, Stat Med, 13, 873, 10.1002/sim.4780130808 Campbell, 1991, Coping with extra Poisson variability in the analysis of factors influencing vaginal ring expulsions, Stat Med, 10, 241, 10.1002/sim.4780100208 Mishell, 1969, The effect of an oral contraceptive on tests of thyroid function, Fertil Steril, 20, 335, 10.1016/S0015-0282(16)36975-8 Bounds, 1993, Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring, Eur J Obstet Gynecol Reprod Biol, 48, 123, 10.1016/0028-2243(93)90252-8 Henriksson, 1996, A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging, Am J Obstet Gynecol, 174, 85, 10.1016/S0002-9378(96)70378-2 Johansson, 2004, New delivery systems in contraception: Vaginal rings, Am J Obstet Gynecol, 190, S54, 10.1016/j.ajog.2004.01.056 Szycher, 1988, Biostability of polyurethane elastomers: A critical review, J Biomater Appl, 3, 297, 10.1177/088532828800300207 Szycher M,Reed AM.1996.Medical-grade polyurethanes: A critical review. Annual Technical Conference—Society of Plastics Engineers 54th (Vol. 3)2758–2766. Deanin, 1991, Structure-property relations in polyurethanes, 51 Yui, 1986, Drug release from monolithic devices of segmented polyether-poly(urethane urea)s having both hydrophobic and hydrophilic soft segments, Makromolekulare Chemie, Rapid Communications, 7, 747, 10.1002/marc.1986.030071112 Touitou, 1984, The release mechanism of drugs from polyurethane transdermal delivery systems, Int J Pharm, 19, 323, 10.1016/0378-5173(84)90061-9 Sreenivasan, 2001, Effect of blending methyl b-cyclodextrin on the release of hydrophobic hydrocortisone into water from polyurethane, J Appl Polym Sci, 81, 520, 10.1002/app.1466 Chaudhuri, 1988, Polyether polyurethane delivery systems. I. Evaluation of monolithic systems for N6-(D2-isopentenyl)adenosine, Int J Pharm, 42, 117, 10.1016/0378-5173(88)90167-6 Pulat, 2006, The release of bovine serum albumin from polyurethane based hydrophilic and hydrophobic disks and microbiological interactions, Biomed Mater Eng, 16, 147 Stokes, 1995, Polyurethane elastomer biostability, J Biomater Appl, 9, 321, 10.1177/088532829500900402 Tang, 2001, Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity, Pharm Dev Technol, 6, 531, 10.1081/PDT-120000291 Ferreira, 2003, Partition and location of nimesulide in EPC liposomes: a spectrophotometric and fluorescence study, Analytical and Bioanalytical Chemistry, 377, 293, 10.1007/s00216-003-2089-5 MacDonald, 1991, Small-volume extrusion apparatus for preparation of large, unilamellar vesicles, Biochim Biophys Acta, 1061, 297, 10.1016/0005-2736(91)90295-J van Laarhoven, 2002, In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring, Int J Pharm, 232, 163, 10.1016/S0378-5173(01)00900-0 Markarian, 2004, Processing and recycling advantages drive growth in thermoplastic elastomers, Plastics Additives Compound, 6, 22 Yui, 1988, Novel design of microreservoir-dispersed matrixes for drug delivery formulations: Drug release from polybutadiene- and poly(ethylene oxide)-based segmented polyurethanes in relation to their microdomain structures, J Bioactive Compatible Polym, 3, 106, 10.1177/088391158800300202 Yui, 1987, Novel design of microreservoir-dispersed matrixes for drug delivery formulations: Regulative drug release from poly(ethylene oxide)- and poly(tetramethylene oxide)-based segmented polyurethanes, J Control Release, 6, 329, 10.1016/0168-3659(87)90086-1 Chien, 1975, Solution-solubility dependency of controlled release of drug from polymer matrix: Mathematical analysis, J Pharm Sci, 64, 1643, 10.1002/jps.2600641011 Hussain, 2005, The vagina as a route for systemic drug delivery, J Control Release, 103, 301, 10.1016/j.jconrel.2004.11.034 Sueyoshi, 1932, Studies on the physicochemical properties of lecithin, J Biochem (Tokyo, Japan), 15, 277